Brand vs generic prescription spending share U.S. 2017-2021

Market Intelligence Report: Antidiabetic Drugs, 2012-2021

US Medicaid program: An analysis of the spending and utilization patterns for antidepressants from 2017 to 2021 - ScienceDirect

Pricing & Reimbursement Laws and Regulations, USA

Prescription Medicines: Costs in Context June 2022

US Branded Generics Market was valued at US$ 19.1 billion in 2022 and is Projected to witness a Decent Growth Rate of ~9-10% by 2027

Spending on total dispensed Rx vs. generic Rx in U.S. by formulation 2017

Chart: Few Pricey Medications Cause Bulk of Medicare Drug Spending

A Comparison of Brand-Name Drug Prices Among Selected Federal Programs

Home OECD iLibrary

Branded Generics Market - Global Industry Analysis and Forecast

How Much Does the United States Spend on Prescription Drugs Compared to Other Countries?